Related references
Note: Only part of the references are listed.Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis
Eryun Zhang et al.
NATURE COMMUNICATIONS (2022)
The metabolic impact of small intestinal nutrient sensing
Frank A. Duca et al.
NATURE COMMUNICATIONS (2021)
Small intestinal taurochenodeoxycholic acid-FXR axis alters local nutrient-sensing glucoregulatory pathways in rats
T. M. Zaved Waise et al.
MOLECULAR METABOLISM (2021)
Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis
Severine Olivier et al.
MOLECULAR METABOLISM (2021)
Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production
T. M. Zaved Waise et al.
NATURE COMMUNICATIONS (2019)
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
Yu Wang et al.
CELL REPORTS (2019)
Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes
Malcolm J. Borg et al.
DIABETES OBESITY & METABOLISM (2019)
Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway
Paige V. Bauer et al.
CELL METABOLISM (2018)
A Gut Feeling for Metformin
David Z. I. Cherney et al.
CELL METABOLISM (2018)
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun et al.
NATURE MEDICINE (2018)
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
John B. Buse et al.
DIABETES CARE (2016)
Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats
Frank A. Duca et al.
NATURE MEDICINE (2015)
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Russell A. Miller et al.
NATURE (2013)
Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect
D Stepensky et al.
DRUG METABOLISM AND DISPOSITION (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
